Clinical Trial

A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction

Study acronym: EXSTACY
Recruiting
View on ClinicalTrials.gov →
Summary
This is a device study (while the device has been patented and cleared by the FDA, the indication of the use for Erectile Dysfunction has been yet approve). EXSTACY is a study to collect information on which patients who have trouble getting or keeping an erection rigid enough for sex (sometimes known as Erectile Dysfunction or ED) benefit from light intensity shockwave therapy (LI-SWT). LI-SWT is a form of energy transfer to the penis that has been shown to help some men with ED in studies over the past decade. This study will collect information about patients prior to treatment to determine what predicts a good outcome. The investigators hope that this information will help decide which patients are likely to benefit from LI-SWT and which patients should consider other treatments for ED.
Trial Details
NCT Number NCT07592533
Lead Sponsor University of California, San Francisco
Conditions Erectile Dysfunction
Enrollment 157 participants
Start Date 2024-09-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18